MA44676A - Compositions de disulfure de sélénium destinées à être utilisées dans le traitement du dysfonctionnement de la glande de meibomius - Google Patents
Compositions de disulfure de sélénium destinées à être utilisées dans le traitement du dysfonctionnement de la glande de meibomiusInfo
- Publication number
- MA44676A MA44676A MA044676A MA44676A MA44676A MA 44676 A MA44676 A MA 44676A MA 044676 A MA044676 A MA 044676A MA 44676 A MA44676 A MA 44676A MA 44676 A MA44676 A MA 44676A
- Authority
- MA
- Morocco
- Prior art keywords
- meibomius
- compositions
- treatment
- gland dysfunction
- selenium disulphide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662322627P | 2016-04-14 | 2016-04-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA44676A true MA44676A (fr) | 2019-02-20 |
Family
ID=60041489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA044676A MA44676A (fr) | 2016-04-14 | 2017-04-13 | Compositions de disulfure de sélénium destinées à être utilisées dans le traitement du dysfonctionnement de la glande de meibomius |
Country Status (12)
Country | Link |
---|---|
US (3) | US11040062B2 (fr) |
EP (1) | EP3442519A4 (fr) |
JP (3) | JP6919970B2 (fr) |
KR (1) | KR102414557B1 (fr) |
CN (2) | CN109310665A (fr) |
AU (1) | AU2017250509B2 (fr) |
BR (1) | BR112018070852B1 (fr) |
CA (1) | CA3019349A1 (fr) |
IL (1) | IL262212B (fr) |
MA (1) | MA44676A (fr) |
MX (1) | MX2018012390A (fr) |
WO (1) | WO2017178892A2 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080114423A1 (en) | 2006-05-15 | 2008-05-15 | Grenon Stephen M | Apparatus for inner eyelid treatment of meibomian gland dysfunction |
US20090043365A1 (en) | 2005-07-18 | 2009-02-12 | Kolis Scientific, Inc. | Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma |
US8083787B2 (en) | 2005-07-18 | 2011-12-27 | Tearscience, Inc. | Method and apparatus for treating meibomian gland dysfunction |
US20070060988A1 (en) | 2005-07-18 | 2007-03-15 | Grenon Stephen M | Melting meibomian gland obstructions |
US7981145B2 (en) | 2005-07-18 | 2011-07-19 | Tearscience Inc. | Treatment of meibomian glands |
US9463201B2 (en) | 2014-10-19 | 2016-10-11 | M.G. Therapeutics Ltd | Compositions and methods for the treatment of meibomian gland dysfunction |
AU2016332966A1 (en) * | 2015-09-28 | 2018-04-26 | Azura Ophthalmics Ltd. | Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion |
MX2018012390A (es) | 2016-04-14 | 2019-07-04 | Azura Ophthalmics Ltd | Composiciones de disulfuro de selenio para usarse en el tratamiento de la disfuncion de las glandulas de meibomio. |
WO2021090058A2 (fr) * | 2019-11-04 | 2021-05-14 | Azura Ophthalmics Ltd. | Dose mesurée contre demodex et les troubles associés à celui-ci |
EP4054703A4 (fr) * | 2019-11-04 | 2023-12-13 | Azura Ophthalmics Ltd | Dose mesurée pour des troubles dans ou autour de l'oeil |
EP4084803A4 (fr) * | 2020-01-02 | 2024-02-21 | Azura Ophthalmics Ltd | Fabrication de compositions de disulfure de sélénium |
CA3166357A1 (fr) | 2020-01-10 | 2021-07-15 | Azura Ophthalmics Ltd. | Instructions pour composition et sensibilite |
CA3223719A1 (fr) * | 2021-06-24 | 2022-12-29 | Charles Bosworth | Compositions et methodes d'amelioration de la vision |
CN114159322B (zh) * | 2021-12-09 | 2023-04-18 | 江苏知原药业股份有限公司 | 一种二硫化硒洗发水及提高二硫化硒洗发水稳定性的方法 |
Family Cites Families (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3236730A (en) | 1962-01-04 | 1966-02-22 | Miles Lab | Blepharitis composition comprising antiseptic, quaternary ammonium compound, keratolytic agent and a chelating compound |
US5602130A (en) | 1987-03-20 | 1997-02-11 | Allergan | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
US5645827A (en) | 1992-09-30 | 1997-07-08 | Union Carbide Chemicals & Plastics Technology Corporation | Muco-adhesive polymers |
CN1050748C (zh) | 1993-04-22 | 2000-03-29 | 孟丽君 | 表面麻醉涂膜剂的制备方法 |
JP2891883B2 (ja) | 1993-11-05 | 1999-05-17 | 学校法人近畿大学 | 抗白内障医薬組成物 |
FR2728163A1 (fr) * | 1994-12-20 | 1996-06-21 | Oreal | Composition cosmetique, dermatologique ou pharmaceutique stable contenant du disulfure de selenium et au moins un sel de zinc |
WO1997020578A1 (fr) | 1995-12-04 | 1997-06-12 | University Of Miami | Corticosteroide sans conservateur pour application locale, destine au traitement du syndrome de l'oeil sec, de la keratite filamenteuse, et du retard de clairance lacrymale |
US5965606A (en) | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
EP0930072A1 (fr) | 1998-01-13 | 1999-07-21 | Kartar Dr. Lalvani | Composition à base de minéraux et de vitamines, pour le traitement de l'oeil sec |
JP3407654B2 (ja) | 1998-04-14 | 2003-05-19 | ライオン株式会社 | 眼科用組成物 |
US6348508B1 (en) | 2000-04-04 | 2002-02-19 | Bausch & Lomb Incorporated | Method for treating dry eye |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
FR2832637B1 (fr) | 2001-06-07 | 2004-07-30 | Lefaix Marie Therese Droy | Utilisation d'un antioxydant pour la fabrication d'un medicament destine au traitement des affections oculaires de surface |
AU2002334205B2 (en) | 2001-10-26 | 2007-07-05 | Istituto Di Ricerche Di Biologia Molecolara P. Angeletti Spa | Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
FR2833268B1 (fr) | 2001-12-12 | 2005-07-08 | Fabre Pierre Dermo Cosmetique | Nouvelle association contenant un poloxamer et de l'acide chondroitine sulfurique et/ou une glycoproteine et son utilisation |
KR100564386B1 (ko) | 2002-05-13 | 2006-03-27 | 주식회사 마이코플러스 | 4-하이드록시-5-메톡시-4-[2-메틸-3-(3-메틸-2-부테닐)-2-옥시란닐]-1-옥사스피로[2,5]옥탄-6-온을 함유한 지루치료용 약제학적 조성물 |
US8420699B1 (en) | 2002-06-19 | 2013-04-16 | Irvine L. Dubow | Composition and methods of treatment using deionized and ozonated solution |
CA2492989C (fr) | 2002-07-23 | 2012-11-20 | Novartis Ag | Composition d'onguent ophtalmique comprenant un medicament, une base d'onguent et un agent de solubilisation/dispersion |
EP1545207B1 (fr) | 2002-08-19 | 2018-03-14 | Ira Sanders | Traitement d'un dysfonctionnement de la glande holocrine au moyen de neurotoxines clostridiales |
US20040171561A1 (en) | 2002-09-03 | 2004-09-02 | Popp Karl F. | Topical formulations for treatment of rosacea |
EP1551399A4 (fr) | 2002-09-30 | 2011-01-05 | Mark A Babizhayev | Methode de traitement topique de maladies de l'oeil, composition et dispositif pour ce traitement |
US20060188471A1 (en) * | 2002-10-31 | 2006-08-24 | Podolsky Daniel K | Methods of treating epithelial lesions |
GB0225795D0 (en) | 2002-11-05 | 2002-12-11 | Guillon Michael | Wipes |
US20070269537A1 (en) | 2003-02-10 | 2007-11-22 | Bioderm Research | Skin Condition Improvement Including Acne, Rosacea, and Topical Wounds by Artemisia Annua Extract via Iron Siderophore Trojan Horse Delivery System |
GB0322448D0 (en) | 2003-09-25 | 2003-10-29 | Lamellar Therapeutics Ltd | Using lamellar bodies to modify linear biological macro molecules |
JP2007517893A (ja) | 2004-01-10 | 2007-07-05 | バイオリピッド インコーポレイテッド | 脂質組成物及び該脂質組成物の使用方法 |
GB0404693D0 (en) | 2004-03-02 | 2004-04-07 | Univ London | Pharmaceutical preparations for the treatment of ocular surface and other disorders |
US20050197614A1 (en) | 2004-03-04 | 2005-09-08 | Wilson Pritchard | Occlusive biomedical devices, punctum plugs, and methods of use thereof |
US8455016B2 (en) | 2004-03-12 | 2013-06-04 | Melbj Holdings, Llc | Treatment for meibomian gland dysfunction or obstruction |
US20050202097A1 (en) | 2004-03-12 | 2005-09-15 | Melbj Holdings, Llc, Florida | Lubricant for the ocular surface |
EP1793875B9 (fr) | 2004-06-16 | 2010-09-08 | Affinergy, Inc. | Biomateriaux interfaciaux favorisant l'adherence specifique de sunstances a analyser |
EP1621191A1 (fr) * | 2004-07-29 | 2006-02-01 | Werner Bollag | Traitement de maladies inflammatoires avec des antagonistes du RXR |
WO2006119174A1 (fr) | 2005-04-30 | 2006-11-09 | Ocular Surface Center, P.A. | Methode de traitement oculaire de demodex |
JPWO2006137426A1 (ja) | 2005-06-22 | 2009-01-22 | 興和株式会社 | 角結膜疾患の予防又は治療剤 |
US7981095B2 (en) | 2005-07-18 | 2011-07-19 | Tearscience, Inc. | Methods for treating meibomian gland dysfunction employing fluid jet |
US8083787B2 (en) | 2005-07-18 | 2011-12-27 | Tearscience, Inc. | Method and apparatus for treating meibomian gland dysfunction |
WO2013003594A2 (fr) | 2011-06-28 | 2013-01-03 | Tearscience, Inc. | Procédés et systèmes de traitement de dysfonctionnement de la glande de meibomius à l'aide d'énergie radiofréquence |
WO2007070463A2 (fr) | 2005-12-12 | 2007-06-21 | Riolan Technologies, Inc. | Compositions, procedes et kits pour eliminer des debris d’une region oculaire |
CA2651815A1 (fr) | 2006-05-10 | 2007-11-22 | Dxterity Diagnostics | Detection de cibles d'acides nucleiques au moyen de sondes oligonucleotidiques chimiquement reactives |
AU2007266260B2 (en) | 2006-05-31 | 2012-07-19 | Medihoney Pty Ltd | Medicinal compositions containing honey |
US20090123527A1 (en) | 2006-07-24 | 2009-05-14 | Akorn, Inc. | Method of inducing topical anesthesia and transdermal patch |
US20080021068A1 (en) | 2006-07-24 | 2008-01-24 | Akorn, Inc. | Aqueous gel formulation and method for inducing topical anesthesia |
WO2008027069A1 (fr) | 2006-08-21 | 2008-03-06 | Tearscience, Inc. | Procédé et appareil de traitement du dysfonctionnement de la glande de meibomius au moyen d'un fluide |
US8249695B2 (en) | 2006-09-29 | 2012-08-21 | Tearscience, Inc. | Meibomian gland imaging |
US8090426B2 (en) | 2006-10-27 | 2012-01-03 | Felder Robin A | Microelectronic biosensor plug |
US20100204317A1 (en) | 2006-11-03 | 2010-08-12 | Qlt Inc. | Methods of treating dermatological disorders or conditions |
WO2008068866A1 (fr) | 2006-11-30 | 2008-06-12 | Menicon Co., Ltd. | Composition ophtalmique |
BRPI0808410A2 (pt) | 2007-02-28 | 2015-06-23 | Aciex Therapeutics Inc | Métodos e composições para normalizar secreções da glândula meibomiana |
EP2136800A4 (fr) | 2007-03-19 | 2011-10-05 | Wisconsin Alumni Res Found | Modulation de la détection du quorum bactérien avec des ligands synthétiques |
US8128968B2 (en) | 2007-08-29 | 2012-03-06 | Tissuetech, Inc. | Compositions and methods for treating Demodex infestations |
JP5668476B2 (ja) | 2007-10-08 | 2015-02-12 | オーリニア・ファーマシューティカルズ・インコーポレイテッドAurinia Pharmaceuticals Inc. | カルシニューリン阻害剤またはmTOR阻害剤を含む眼科用組成物 |
JP2011515494A (ja) | 2008-03-26 | 2011-05-19 | エリック ドネンフェルド, | テトラサイクリンファミリー抗生物質を用いる、眼瞼縁および涙液膜機能の改善ならびに眼瞼縁疾患の処置のための方法 |
CN104623741A (zh) * | 2008-04-30 | 2015-05-20 | 马缇医疗股份有限公司 | 复合泪管植入物及相关方法 |
US8716238B2 (en) | 2008-07-10 | 2014-05-06 | Allergan, Inc. | Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
US20120028929A1 (en) | 2008-09-19 | 2012-02-02 | Alacrity Bioscience, Inc. | Tetracycline stabilizing formulations |
US9888839B2 (en) | 2009-04-01 | 2018-02-13 | Tearscience, Inc. | Methods and apparatuses for determining contact lens intolerance in contact lens wearer patients based on dry eye tear film characteristic analysis and dry eye symptoms |
CA2760591C (fr) | 2009-05-01 | 2018-01-02 | Advanced Vision Research, Inc. | Compositions de nettoyant et procedes d'utilisation de celles-ci |
WO2011006079A2 (fr) | 2009-07-10 | 2011-01-13 | Lyotropoic Therapeutics, Inc. | Formulations ophtalmiques de matériaux en phase cristalline liquide inversée en procédés dutilisation de celles-ci |
CN101612161A (zh) * | 2009-08-07 | 2009-12-30 | 魏谠全 | 一种眼药组合物及其制剂 |
CN102038953B (zh) | 2009-10-14 | 2012-07-18 | 上海昊海生物科技股份有限公司 | 一种眼科手术前局部麻醉用组合物及其制备方法和用途 |
EP3569223A1 (fr) | 2009-10-30 | 2019-11-20 | Intratus, Inc. | Procédés et compositions pour une libération prolongée de médicaments |
EP2506843A4 (fr) | 2009-12-02 | 2013-04-17 | Bridge Pharma Inc | Traitement de la xérophtalmie avec des composés qui augmentent la sécrétion de la glande de meibomius |
KR20120115380A (ko) * | 2010-01-11 | 2012-10-17 | 지티엑스, 인코포레이티드 | 마이봄선 기능 장애의 치료 방법 |
CN103037802B (zh) | 2010-03-31 | 2016-08-24 | 奥库杰克特有限责任公司 | 用于眼内药物递送的设备和方法 |
US8304840B2 (en) | 2010-07-29 | 2012-11-06 | Taiwan Semiconductor Manufacturing Company, Ltd. | Spacer structures of a semiconductor device |
US20120093876A1 (en) | 2010-10-13 | 2012-04-19 | Aciex, Inc. | Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions |
WO2012063237A2 (fr) | 2010-11-08 | 2012-05-18 | Healor Ltd. | Compositions ophtalmiques tamponnées et leurs procédés d'utilisation |
WO2012092375A1 (fr) | 2010-12-29 | 2012-07-05 | Inspire Pharmaceuticals, Inc. | Méthode pour traiter l'œil sec |
WO2012092378A1 (fr) | 2010-12-29 | 2012-07-05 | Inspire Pharmaceuticals, Inc. | Méthode de traitement de la blépharite |
WO2012092320A2 (fr) | 2010-12-29 | 2012-07-05 | Nichamin Louis D | Traitement oculaire |
MY175318A (en) | 2011-01-26 | 2020-06-19 | Allergan Inc | Androgen composition for treating an opthalmic condition |
PE20141070A1 (es) | 2011-05-12 | 2014-09-14 | Foresigth Biotherapeutics Inc | Composiciones estables de povidona yodada con antiinflamatorios esteroideos o no esteroideos |
KR20140039217A (ko) | 2011-05-20 | 2014-04-01 | 각고호우징 게이오기주크 | 신규 금속 단백질 및 그 제조 방법, 그리고 상기 금속 단백질을 함유하는 각결막 질환의 예방 또는 치료제 |
KR20140054002A (ko) | 2011-06-29 | 2014-05-08 | 인사이트 비젼 인코포레이티드 | 재발성 눈꺼풀판샘 장애를 치료하는 방법 및 이로 인해 재발 빈도를 감소시키는 방법 |
ITFI20120044A1 (it) | 2012-03-01 | 2013-09-02 | Biodue Spa | Formulazione ad uso oftalmico comprendente olio di jojoba. |
KR102113998B1 (ko) | 2012-04-16 | 2020-05-25 | 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 | 피부 및/또는 점막의 치료 및/또는 관리용 화합물 및 미용적 또는 약학적 조성물에서의 이의 용도 |
EP2664330A1 (fr) | 2012-05-15 | 2013-11-20 | F. Holzer GmbH | Composition et médicament comprenant des acides gras oméga 3 ainsi qu'un glycosaminoglycane |
CA2888647A1 (fr) | 2012-11-20 | 2014-05-30 | Revive Therapeutics Inc. | Utilisation de bucillamine dans le traitement de la goutte |
US9211397B2 (en) | 2012-12-19 | 2015-12-15 | Senju Usa, Inc. | Patch for treatment of eyelid disease containing clobetasol |
CA2898644A1 (fr) | 2013-01-24 | 2014-07-31 | Rigel Pharmaceuticals, Inc. | Composition pour administration ophtalmique |
US9987235B2 (en) | 2013-08-01 | 2018-06-05 | Nicholas L. Abbott | Methods and compositions for modifying mucous membranes |
CA2920815C (fr) | 2013-08-14 | 2021-09-21 | Kalvista Pharmaceuticals Limited | Inhibiteurs de la kallicreine plasmatique |
DK3139903T3 (da) | 2014-05-07 | 2019-09-09 | Croma Pharma Ges M B H | Vandig oftalmisk opløsning og fremgangsmåde til behandling af tørre øjne-syndrom |
EP3151827A4 (fr) | 2014-06-04 | 2018-01-24 | Tersus Pharmaceuticals, LLC | Méthodes de traitement de la sécheresse oculaire chronique en utilisant du c16:1n7-palmitoléate et ses dérivés |
US9463201B2 (en) | 2014-10-19 | 2016-10-11 | M.G. Therapeutics Ltd | Compositions and methods for the treatment of meibomian gland dysfunction |
WO2016066195A1 (fr) | 2014-10-29 | 2016-05-06 | Laboratoire Medidom Sa | Formulation stérilisée à la chaleur comprenant du chitosane et son procédé de préparation |
JPWO2016140242A1 (ja) | 2015-03-03 | 2018-02-01 | 日油株式会社 | 点眼剤 |
AU2016332966A1 (en) | 2015-09-28 | 2018-04-26 | Azura Ophthalmics Ltd. | Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion |
CN105456287B (zh) | 2015-12-03 | 2017-06-30 | 大有药业扬州有限公司 | 二硫化硒超微粉体及其制备方法 |
MX2018012390A (es) | 2016-04-14 | 2019-07-04 | Azura Ophthalmics Ltd | Composiciones de disulfuro de selenio para usarse en el tratamiento de la disfuncion de las glandulas de meibomio. |
EP3445352A4 (fr) | 2016-04-19 | 2019-12-11 | Azura Opthalmics Ltd. | Compositions pour le traitement de troubles liés à l'hyperkératose |
WO2020208418A1 (fr) | 2019-04-12 | 2020-10-15 | Azura Ophthalmics Ltd. | Compositions et procédés pour le traitement d'inconfort des lentilles de contact |
-
2017
- 2017-04-13 MX MX2018012390A patent/MX2018012390A/es unknown
- 2017-04-13 CA CA3019349A patent/CA3019349A1/fr active Pending
- 2017-04-13 JP JP2018549302A patent/JP6919970B2/ja active Active
- 2017-04-13 CN CN201780037243.4A patent/CN109310665A/zh active Pending
- 2017-04-13 EP EP17782001.6A patent/EP3442519A4/fr active Pending
- 2017-04-13 AU AU2017250509A patent/AU2017250509B2/en active Active
- 2017-04-13 WO PCT/IB2017/000542 patent/WO2017178892A2/fr active Application Filing
- 2017-04-13 BR BR112018070852-6A patent/BR112018070852B1/pt active IP Right Grant
- 2017-04-13 US US16/093,615 patent/US11040062B2/en active Active
- 2017-04-13 KR KR1020187032310A patent/KR102414557B1/ko active IP Right Grant
- 2017-04-13 MA MA044676A patent/MA44676A/fr unknown
- 2017-04-13 CN CN202210056357.6A patent/CN114469991A/zh active Pending
-
2018
- 2018-10-08 IL IL262212A patent/IL262212B/en unknown
-
2021
- 2021-05-14 US US17/320,731 patent/US12011457B2/en active Active
- 2021-07-19 JP JP2021118850A patent/JP2021181449A/ja active Pending
-
2023
- 2023-06-15 JP JP2023098739A patent/JP2023134452A/ja active Pending
-
2024
- 2024-05-15 US US18/665,222 patent/US20240299445A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112018070852B1 (pt) | 2024-01-16 |
WO2017178892A2 (fr) | 2017-10-19 |
US12011457B2 (en) | 2024-06-18 |
CN114469991A (zh) | 2022-05-13 |
EP3442519A2 (fr) | 2019-02-20 |
CN109310665A (zh) | 2019-02-05 |
JP6919970B2 (ja) | 2021-08-18 |
KR20180129920A (ko) | 2018-12-05 |
AU2017250509B2 (en) | 2023-03-02 |
JP2019513705A (ja) | 2019-05-30 |
AU2017250509A1 (en) | 2018-10-18 |
JP2023134452A (ja) | 2023-09-27 |
CA3019349A1 (fr) | 2017-10-19 |
KR102414557B1 (ko) | 2022-06-28 |
JP2021181449A (ja) | 2021-11-25 |
IL262212A (en) | 2018-11-29 |
EP3442519A4 (fr) | 2019-12-04 |
US11040062B2 (en) | 2021-06-22 |
US20210330703A1 (en) | 2021-10-28 |
MX2018012390A (es) | 2019-07-04 |
WO2017178892A3 (fr) | 2017-11-23 |
IL262212B (en) | 2021-07-29 |
US20200281966A1 (en) | 2020-09-10 |
BR112018070852A2 (pt) | 2019-02-05 |
US20240299445A1 (en) | 2024-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA44676A (fr) | Compositions de disulfure de sélénium destinées à être utilisées dans le traitement du dysfonctionnement de la glande de meibomius | |
IL280209A (en) | Preparations and methods for treating meibomian gland dysfunction | |
MA45192A (fr) | Traitement d'association | |
MA49760A (fr) | Mavacamten destiné à être utilisé dans le traitement de la cardiomyopathie hypertrophique | |
DK3490582T3 (da) | Sammensætninger til anvendelse i behandling af myelofibrose | |
MA45073A (fr) | Nouveaux peptides, combinaison de peptides et d'échafaudages destinés à être utilisés dans le traitement immunothérapeutique de divers cancers | |
FR3046933B1 (fr) | Inhibiteurs nlrp3 pour le traitement des pathologies cutanees inflammatoires | |
MA43283A (fr) | Procédés et compositions pour le traitement du cancer | |
MA39722A (fr) | Composition pour son utilisation dans une methode de traitement ou de prevention de l'anemie par l'inhibition de l'activine b et du gdf11 | |
MA46608A (fr) | Formulation liposomale destinée à être utilisée dans le traitement du cancer | |
IT201600121601A1 (it) | Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo | |
MA43825A (fr) | Schémas posologiques pour le traitement d'infections fongiques | |
MA45552A (fr) | Compositions destinées au traitement de l'amylose | |
MA47111A (fr) | Agents ciblant sirpgamma destinés à être utilisés dans le traitement du cancer | |
MA53873A (fr) | Compositions et procédés pour le traitement de la presbytie | |
ES2981657T3 (es) | Composiciones para uso en el tratamiento de la hipertensión | |
MA43230A (fr) | Méthodes et compositions pour le traitement d'une épidermolyse bulleuse | |
MA43106A (fr) | Traitement de l'oligo-ovulation associée à la stéatose hepatique | |
MA49524A (fr) | Compositions d'antagoniste de nk-1 et méthodes destinées à être utilisées dans le traitement de la dépression | |
FR3032499B1 (fr) | Ecrou pour le blocage axial d'une bague de palier dans une turbomachine | |
MA45973A (fr) | Combinaisons d'inhibiteurs de btk pour le traitement du myélome multiple | |
EA201791937A1 (ru) | Противовоспалительные полипептиды | |
MA51128A (fr) | Inhibiteurs c5ar destinés à être utilisés dans le traitement de la douleur iatrogène induite par la chimiothérapie | |
MA43051A (fr) | Polythérapie pour le traitement d'une du vhc | |
IT201700111939A1 (it) | Composizione farmaceutica per l’uso nel trattamento di stati infiammatori |